163 related articles for article (PubMed ID: 18927126)
1. Identification of a common variant at the NOS1AP locus strongly associated to QT-interval duration.
Eijgelsheim M; Aarnoudse AL; Rivadeneira F; Kors JA; Witteman JC; Hofman A; van Duijn CM; Uitterlinden AG; Stricker BH
Hum Mol Genet; 2009 Jan; 18(2):347-57. PubMed ID: 18927126
[TBL] [Abstract][Full Text] [Related]
2. Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study.
Aarnoudse AJ; Newton-Cheh C; de Bakker PI; Straus SM; Kors JA; Hofman A; Uitterlinden AG; Witteman JC; Stricker BH
Circulation; 2007 Jul; 116(1):10-6. PubMed ID: 17576865
[TBL] [Abstract][Full Text] [Related]
3. Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study.
Lehtinen AB; Newton-Cheh C; Ziegler JT; Langefeld CD; Freedman BI; Daniel KR; Herrington DM; Bowden DW
Diabetes; 2008 Apr; 57(4):1108-14. PubMed ID: 18235038
[TBL] [Abstract][Full Text] [Related]
4. A common variant of NOS1AP is associated with QT interval duration in a Chinese population with Type 2 diabetes.
Lu J; Hu C; Hu W; Zhang R; Wang C; Qin W; Yu W; Xiang K; ; Jia W
Diabet Med; 2010 Sep; 27(9):1074-9. PubMed ID: 20722683
[TBL] [Abstract][Full Text] [Related]
5. Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations.
Kao WH; Arking DE; Post W; Rea TD; Sotoodehnia N; Prineas RJ; Bishe B; Doan BQ; Boerwinkle E; Psaty BM; Tomaselli GF; Coresh J; Siscovick DS; Marbán E; Spooner PM; Burke GL; Chakravarti A
Circulation; 2009 Feb; 119(7):940-51. PubMed ID: 19204306
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome.
Tomás M; Napolitano C; De Giuli L; Bloise R; Subirana I; Malovini A; Bellazzi R; Arking DE; Marban E; Chakravarti A; Spooner PM; Priori SG
J Am Coll Cardiol; 2010 Jun; 55(24):2745-52. PubMed ID: 20538168
[TBL] [Abstract][Full Text] [Related]
7. Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2.
Kolder ICRM; Tanck MWT; Postema PG; Barc J; Sinner MF; Zumhagen S; Husemann A; Stallmeyer B; Koopmann TT; Hofman N; Pfeufer A; Lichtner P; Meitinger T; Beckmann BM; Myerburg RJ; Bishopric NH; Roden DM; Kääb S; Wilde AAM; Schott JJ; Schulze-Bahr E; Bezzina CR
Circ Cardiovasc Genet; 2015 Jun; 8(3):447-456. PubMed ID: 25737393
[TBL] [Abstract][Full Text] [Related]
8. Common candidate gene variants are associated with QT interval duration in the general population.
Marjamaa A; Newton-Cheh C; Porthan K; Reunanen A; Lahermo P; Väänänen H; Jula A; Karanko H; Swan H; Toivonen L; Nieminen MS; Viitasalo M; Peltonen L; Oikarinen L; Palotie A; Kontula K; Salomaa V
J Intern Med; 2009 Apr; 265(4):448-58. PubMed ID: 19019189
[TBL] [Abstract][Full Text] [Related]
9. A NOS1AP gene variant is associated with a paradoxical increase of the QT-interval shortening effect of digoxin.
Soroush N; Aarnoudse AJ; Kavousi M; Kors JA; Ikram MA; Newton-Cheh C; Ahmadizar F; Stricker BH
Pharmacogenomics J; 2022 Feb; 22(1):55-61. PubMed ID: 34616002
[TBL] [Abstract][Full Text] [Related]
10. Associations between NOS1AP single nucleotide polymorphisms (SNPs) and QT interval duration in four racial/ethnic groups in the Multi-Ethnic Study of Atherosclerosis (MESA).
Shah SA; Herrington DM; Howard TD; Divers J; Arnett DK; Burke GL; Kao WH; Guo X; Siscovick DS; Chakravarti A; Lima JA; Psaty BM; Tomaselli GF; Rich SS; Bowden DW; Post W
Ann Noninvasive Electrocardiol; 2013 Jan; 18(1):29-40. PubMed ID: 23347024
[TBL] [Abstract][Full Text] [Related]
11. Multiple independent genetic factors at NOS1AP modulate the QT interval in a multi-ethnic population.
Arking DE; Khera A; Xing C; Kao WH; Post W; Boerwinkle E; Chakravarti A
PLoS One; 2009; 4(1):e4333. PubMed ID: 19180230
[TBL] [Abstract][Full Text] [Related]
12. An enhancer polymorphism at the cardiomyocyte intercalated disc protein NOS1AP locus is a major regulator of the QT interval.
Kapoor A; Sekar RB; Hansen NF; Fox-Talbot K; Morley M; Pihur V; Chatterjee S; Brandimarto J; Moravec CS; Pulit SL; ; Pfeufer A; Mullikin J; Ross M; Green ED; Bentley D; Newton-Cheh C; Boerwinkle E; Tomaselli GF; Cappola TP; Arking DE; Halushka MK; Chakravarti A
Am J Hum Genet; 2014 Jun; 94(6):854-69. PubMed ID: 24857694
[TBL] [Abstract][Full Text] [Related]
13. Common variation in NOS1AP and KCNH2 genes and QT interval duration in young adults. The Cardiovascular Risk in Young Finns Study.
Raitakari OT; Blom-Nyholm J; Koskinen TA; Kähönen M; Viikari JS; Lehtimäki T
Ann Med; 2009; 41(2):144-51. PubMed ID: 18785031
[TBL] [Abstract][Full Text] [Related]
14. NOS1AP Polymorphisms Modify QTc Interval Duration But Not Cardiac Arrest Risk in Hypertrophic Cardiomyopathy.
Earle N; Ingles J; Bagnall RD; Gray B; Crawford J; Smith W; Shelling AN; Love DR; Semsarian C; Skinner JR
J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1346-51. PubMed ID: 26332198
[TBL] [Abstract][Full Text] [Related]
15. Effect of Sex and Underlying Disease on the Genetic Association of QT Interval and Sudden Cardiac Death.
Mitchell RN; Ashar FN; Jarvelin MR; Froguel P; Sotoodehnia N; Brody JA; Sebert S; Huikuri H; Rioux J; Goyette P; Newcomb CE; Junttila MJ; Arking DE
J Am Heart Assoc; 2019 Dec; 8(23):e013751. PubMed ID: 31747862
[TBL] [Abstract][Full Text] [Related]
16. Sex is a moderator of the association between NOS1AP sequence variants and QTc in two long QT syndrome founder populations: a pedigree-based measured genotype association analysis.
Winbo A; Stattin EL; Westin IM; Norberg A; Persson J; Jensen SM; Rydberg A
BMC Med Genet; 2017 Jul; 18(1):74. PubMed ID: 28720088
[TBL] [Abstract][Full Text] [Related]
17. Associations between genetic variants in the NOS1AP (CAPON) gene and cardiac repolarization in the old order Amish.
Post W; Shen H; Damcott C; Arking DE; Kao WH; Sack PA; Ryan KA; Chakravarti A; Mitchell BD; Shuldiner AR
Hum Hered; 2007; 64(4):214-9. PubMed ID: 17565224
[TBL] [Abstract][Full Text] [Related]
18. Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia.
Jamshidi Y; Nolte IM; Dalageorgou C; Zheng D; Johnson T; Bastiaenen R; Ruddy S; Talbott D; Norris KJ; Snieder H; George AL; Marshall V; Shakir S; Kannankeril PJ; Munroe PB; Camm AJ; Jeffery S; Roden DM; Behr ER
J Am Coll Cardiol; 2012 Aug; 60(9):841-50. PubMed ID: 22682551
[TBL] [Abstract][Full Text] [Related]
19. Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations.
Tobin MD; Kähönen M; Braund P; Nieminen T; Hajat C; Tomaszewski M; Viik J; Lehtinen R; Ng GA; Macfarlane PW; Burton PR; Lehtimäki T; Samani NJ
Int J Epidemiol; 2008 Oct; 37(5):1132-41. PubMed ID: 18511491
[TBL] [Abstract][Full Text] [Related]
20. A genome-wide association scan of RR and QT interval duration in 3 European genetically isolated populations: the EUROSPAN project.
Marroni F; Pfeufer A; Aulchenko YS; Franklin CS; Isaacs A; Pichler I; Wild SH; Oostra BA; Wright AF; Campbell H; Witteman JC; Kääb S; Hicks AA; Gyllensten U; Rudan I; Meitinger T; Pattaro C; van Duijn CM; Wilson JF; Pramstaller PP;
Circ Cardiovasc Genet; 2009 Aug; 2(4):322-8. PubMed ID: 20031603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
